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Does the FSH/LH Ratio in the Serum on the Third Day of the
Cycle Predict ICSI Success?
Siklusun 3.Günü Normal FSH Değeri Olan Kadınlarda FSH/LH Oranı ICSI Başarısını
Öngörebilir mi?
Abstract
Objective: To determine whether the follicule stimulating hormone (FSH)/
luteinizing hormone (LH) ratios on the third day of the cycle predict intra-
cytoplasmic sperm injection  (ICSI) outcomes in women with normal day 3 FSH
levels.
Patients and Methods: A retrospective cohort analysis of one hundred and
ninety-nine consecutive women undergoing ICSI treatment with long-down
regulation and recombinant follicular stimulating hormone injections was
carried out  in a University hospital. Four groups were compared in terms of in
vitro fertilization (IVF) outcomes. Groups A, B, C and D consisted of women with
FSH/LH ratios of <1; ≥1 and <1.5; ≥1.5 and ≤2 and >2, respectively. The clinical
pregnancy and implantation rates per transfer were compared. 
Results: There was no significant difference between the groups regarding the
clinical pregnancy or  implantation rates per transfer. 
Conclusion: It appears that the  basal FSH/LH ratio does not predict the cycle
outcome in ICSI cycles in women with normal day 3 FSH levels. (Marmara
Medical Journal 2012;25:69-73)
Key Words: FSH/LH ratio, Pregnancy, ICSI, Cancellation
Özet
Amaç: Siklusun 3.günü normal FSH değeri olan kadınlarda follikül stimule
edici hormon (FSH)/luteinize edici hormon (LH) oranının sitoplazma içi
sperm enjeksiyonu (ICSI) başarısının öngörülebilirliğini araştırmak. 
Hastalar ve Yöntem: Uzun protokol ve rekombinant folikül stimüle edici
hormon kullanılarak ICSI tedavisi alan ardışık yüz doksan dokuz infertil kadın
retrospektif olarak analiz edildi. Grup A, B, C ve D sırasıyla FSH/LH oranları
<1; ≥1 ile <1.5 arası; ≥1.5 ile ≤2 arası ve >2 olan kadınlardan oluşturuldu.
Transfer başına klinik gebelik ve implantasyon oranları karşılaştırıldı. 
Bulgular: Transfer başına klinik gebelik ve implantasyon oranları gruplar arasında
benzer idi. 
Sonuç: Siklusun 3.günü FSH/LH oranı ICSI sikluslarında tedavi sonuçlarını
normal 3. gün FSH seviyesi olan kadınlarda öngöremez. (Marmara
Üniversitesi Tıp Fakültesi Dergisi 2012;25:69-73)
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Introduction
In vitro fertilization (IVF) is a stressful and expensive procedure
for patients who are hoping to get pregnant. Markers of ovarian
reserve were  investigated in order to help predict a patient’s
prognosis, including the likelihood of cycle cancellation, the
required dose of medication, number of oocytes and embryos
generated,  as well as the prognosis for pregnancy.  Ovarian reserve
has been used to predict prognosis in IVF treatments1. Clinical
markers of ovarian reserve include basal (day 3) levels of FSH,
inhibin, and anti-mullerian hormone; antral follicle counts (AFC) and
ovarian volumes2. The day 3 FSH level which is the most widely
used clinical parameter has a limited3 or lower predictive value4.
Women with normal FSH levels on cycle day 3 can require higher
than average doses of medication where disappointing cycle
outcomes can be expected . Better markers of poor prognosis are
needed to identify these patients, to aid in planning their IVF cycles,
and to counsel them as to the likelihood of success. 
Poor ovarian responsiveness and low pregnancy rates (i.e.
diminished ovarian reserve) can be predicted in patients
undergoing one of the assisted reproduction treatments1 on the
basis of several parameters, including: elevated day 3 FSH values5,
abnormal clomiphene citrate challenge tests6, abnormal GnRH-
agonist stimulation tests7, abnormal exogenous FSH ovarian
reserve tests8 or elevated day 3 oestradiol concentrations9 A
number of hormonal parameters are currently thought to be
predictive of  poor ovarian responsiveness to stimulation and low
pregnancy rates in patients undergoing one of the assisted
reproduction treatments1. None of these tests, however, was
found to be sufficiently accurate for predicting the ovarian
response3,4. 
The objective of our study was to evaluate whether the
FSH/LH ratio on cycle day 3 can be used to predict the  ICSI-cycle
outcome in women with normal day 3 FSH values.
Patients and Methods
One hundred and ninety-nine women undergoing
consecutive IVF treatments at the Assisted Reproductive
Techniques (ART) Unit at Marmara University Hospital in Istanbul,
Turkey, were recruited in a retrospective cohort study. Exclusion
criteria were: age over 39 years, cycle day 3 FSH level >12 IU/L,
endometriosis (other than minimal); the presence of only one
ovary or previous ovarian surgery; polycystic ovary syndrome or
other endocrine disorders. In our ART unit, a detailed explanation,
both verbal and written, is given to each infertile couple prior to
ART treatments. Patients gave written consent to publication of
any study derived from aggregate data. Ethical approval for this
study was not required and has not been included as there were
no interventions that are not a part of standard care.  All practices
and protocols conformed to the ethical requirements for assisted
reproductive technology programs of the Ethics Commitee of
Marmara Medical School and it conforms to the provisions of the
Declaration of Helsinki. 
All patients undergoing ART treatment in our institution do
receive intracytoplasmic sperm injection (ICSI) no matter what the
cause of infertility is. Patients were seen on day 3 of the cycle
before their stimulation. On that day, serum samples were
collected in the morning after a 12 h fasting. 5 ml of venous blood
was collected.  All patients underwent a transvaginal ultrasound
documenting  antral follicule count (AFC) by one examiner. All
measurements were performed on one ultrasound machine
(General Electric Loqic 200, 8-4 MHz, Istanbul, Turkey). AFCs
measured all follicles between 2 and 8 mm on each ovary12.  
Subjects commenced down-regulation with a daily subcutenous
injection of  leuprolide acetate (1 mg/mL; Lucrin flacon , Abbott,
Turkey) in the mid-luteal phase of the previous cycle. When adequate
down regulation had been achieved (endometrial thickness <4 mm
or serum estradiol <50 pg/ml), usually after at least 10 days of
leuprolide acetate , controlled ovarian stimulation (COS) was started
with recombinant FSH preparations, either Gonal F (Merck-
Serono,Turkey) or Puregon (Schering-Plough,Turkey) at starting
doses between 150 and 300 IU per day. Dose adjustments were
individualized after 5 days of ovarian stimulation. Final oocyte
maturation was induced by human chorionic gonadotrophin (hCG),
10,000 IU (Pregnyl, Schering-Plough, Turkey) when the two leading
follicles were 18 mm in mean diameter. The analogue was continued
till the day of the  hCG injection. 
Oocytes were retrieved 34 h after hCG administration under
guided vaginal sonography, with the patient in a sedated but
conversant state. An  ICSI procedure was performed 3-5 h after
retrieval of every oocyte. Approximately 16-19 h after the
injection,  normal fertilisation was checked. Selection for embryo
replacement was made according to top quality embryo selection
criteria. Embryos were transferred in a  blastocyte medium (G2,
Vitrolife, SISMED,  Istanbul, Turkey). All embryos were transferred
with the Wallace catheter (Smiths Medical International, UK) on
the third day after ICSI. Abdominal ultrasonographic guidance
was used. Luteal phase support was provided by vaginal
progesterone gel 8% (Crinone, Serono, Turkey) starting on the
day of ovum pick-up. 
Clinical pregnancy was determined by the  presence of a
gestational sac during an ultrasound exam. The implantation rate
was calculated as the ratio between the number of embryonal sacs
diagnosed by sonography and the total number of embryos
transferred into the uterus. Clinical pregnancy rates and
implantation rates were calculated per embryo transfer.
All demographic information, IVF cycle information, and cycle
outcomes were obtained from the patients’ charts. The charts
were reviewed by one investigator. Patients were placed into four
groups for analysis: FSH/LH ratio <1(group A); FSH/LH ratio
between  ≥1 and <1.5 (group B); FSH/LH ratio between ≥1.5 and
≤2 (group C) ,and FSH/LH ratio >2 (group D) . 
Stata/SE 9.2 (Statacorp, Texas) was used for all analyses. For
the whole group statistical evaluation,  the Kruskal-Wallis test was
used; p<0.05 was considered significant. The groups were
compared with eachother by the Mann-Whitney U test. The
Bonferroni adjusted level of significance was  needed to obtain
statistical significance,  calculated as p<0.0083 (0.05/6 = 0.0083).
Multivariable logistic regression modeling was used to
compute the odds ratios (ORs) of variables predictive of clinical
and ongoing pregnancies after fresh ETs , and of the cycle
cancellation rate. The independent variables were age, duration of
stimulation, total dose of FSH administrated, AFC, day 3 FSH
levels, day 3 LH levels and day 3 FSH/LH ratios.
Results
A total of 199 cycles were retropectively analysed. All women
had  a basal FSH value of  less than 12 IU/L. Of the four groups with
FSH/LH ratios of <1; ≥1 and <1.5; ≥1.5 and ≤2; and >2,  group A
included 65, group B 70, group C 43 and group D 21 cycles.
Indications for ICSI in group A were male factor (45.3%), tubal
(7.8%), or unexplained infertility (39.1%). The percentages of
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distribution in group B were 58.6%, 12.9% and 14.3%,
respectively. Indications for ICSI in group C were male factor
(59.5%), tubal (14.3%), or unexplained infertility (14.3%). 71.4%,
5% and 9.5% of women in group D had male factor, tubal, or
unexplained infertility, respectively.
The treatment cycle characteristics  between the groups  are
given in  Table I. ICSI cycle outcomes were comparable between the
groups. The clinical and ongoing pregnancy rates per transfer were
similar. Implantation rates per transfer did not show a significant
difference between the groups  (Table II).
The multivariate analysis showed that there was no association
between  the rate of clinical pregnancy and age, duration of
stimulation, total dose of FSH administered , AFC, day 3 FSH levels,
day 3 LH, or  day 3 FSH/LH ratios  (Table III). There was no
association between the rate of ongoing pregnancy and age,
duration of stimulation, total dose of FSH administered, AFC, day 3
FSH levels, day 3 LH, day 3 FSH/LH ratio  (Table III). The  rate of
cycle cancellation was not associated with age, duration of
stimulation, total dose of FSH administrated  or AFC, day 3 FSH/LH
ratios   (Table III).
Discussion
As the age of the women increases during the reproductive
years, the oocyte population declines together with endocrine
changes that have an  impact on reproductive outcomes.10 A
transient FSH increase in the early follicular phase is the initial
response to ageing , with a normal secretion of estradiol. Cycles
shorten in response to the rise in FSH concentrations and the
consequent stimulation of accelarated follicular development.
Later, increases  of LH levels occur. Higher levels of serum FSH,
increased FSH/LH ratios11 and  elevated concentrations of serum
estradiol12 have been suggested  as  associated  with poor ovarian
responses during assisted conception cycles. However,  no perfect
test or combination of tests has been found to predict the ovarian
response to gonadotropin stimulation during ART cycles. Hence,
studies  are being  conducted regarding this dilemma13.
It is crucial for the infertile couples going through ART to
predict their chances of conception. Thus, an acceptable predictive
parameter is needed for counselling before treatment.  Cycle day 3
Table I. Treatment cycle characteristics between groups 
FSH / LH ratio < 1 ≥1 and <1.5 ≥1.5 and ≤2 >2
Number of cycles 65 70 43 21
Mean FSH (mIU/ml) 5.66±1.66a,b 6.17±1.34c 7.24±2.67a,d  9.39±3.84b,c,d
Mean LH (mIU/ml) 7.80±2.85e 4.98±1.26e 4 .35±1.70e 3.56±1.72e
Age (years) 29.12 ±3.83 29.17±3,63 29.65±2.99 29.48±4.08
Antral Follicule Count (#) 9.23 ± 3.61 8.45 ± 3.55 6.68 ± 2.65 8.07 ± 2.02
Total gonadotropin dose (IU) 2249± 864.2 2580.8±672.3 2332.9±842.4 2503±965.6
Mean duration of COH (days) 8.44±1.67 8.47±1.1.32 8.33±1.31 7.89±1.49
Mean number of oocytes collected (#) 13.45±6,62f 11.93±6.08 11.43±6.5 7.2±3.71f
Metaphase II oocytes (#) 10.60±5.20g 9.4±4.55h 9.34 ±5.39 5.26±2.81g,h
Number of fertilized oocytes (#) 7.33±3.74i 7.02±3.35j 6.33±4.08 3.58±2.19i,j
Percentage of embryos with >6 cells on day 3  (#) 75.42±0,36 61.94±0.4 59,26±0.39 56.86±0.47
Number of embyos transferred on day 3 (#) 2.86±0.43 2.95±0.34k 2.78±0.53 2.53±0.84k
Values shown are mean ± standard deviation (mean ± SD), COH=controlled ovarian hyperstimulation
p value <0.0083 is statistically significant. 
a,j   p=0.002; b,c,e,g    p=0.0001; d,f,i    p=0.001; h       p=0.008; k  p=0.006
Table II. ICSI cycle outcomes of patients
FSH / LH ratio < 1 ≥1 and <1.5 ≥1.5 and ≤2 >2
Number of cycles 65 70 43 21
Cancellation rate (%) 9.23±0.29 11.43±0.32 11.63±0.32 13.63±0.35
Transfer rate (%) 90.77±0.29 88.57±0.32 88.37±0.32 86.36±0.35
Clinical pregnancy rate per transfer (%) 42.37±0.5 37.1±0.49 28.95±0.46 52.63±0.51
Ongoing pregnancy rate per embryo transfer (%) 30.51±0.46 27.42±0.45 21.05±0.41 31.58±0.48
Implantation rate per embryo transfer (%) 18.96±0.29 13.98±0.25 10.53±0.22 14.91±0.27
Values shown are mean ± standard deviation (mean ± SD)
For all comparisons p value >0.0083 
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FSH levels have been proposed for this purpose14,15. FSH
concentration is the result of the feedback effects at the pituitary in
response to the concentrations of inhibin B and estradiol produced
by the follicular cohort16. Since basal FSH concentration is an
indirect marker of ovarian reserve,  it has been used to predict the
cancellation rate in ART17.
The basal FSH concentration has been used as a prognostic
criterion before an ovarian stimulation is started. Dose adjustments of
gonadotropins and preferences for certain protocols have been
planned under the influence of basal FSH concentrations from a
pretreatment cycle. Variations of FSH values between cycles have
been reported18 especially in women with low ovarian reserve due to
their age or to low ovarian responses to ovulation induction.
However,  Penarrubia et al19 have reported no significant inter-cycle
variations in three consecutive cycles. The extent to which inter-cycle
variability might affect patients’ prognosis during ART cycles  has
been questioned. Scott et al.20 and Martin et al.21 advised that such
variability had minimal relevance for the clinical decision. 
Several earlier studies have  investigated ovarian response to
ovulation induction in patients with elevated FSH/LH ratios.
Mukherjee et al.22 reported decreased ovarian responses and lower
pregnancy rates in 14 patients with a FSH/LH ratio >3.6. Barroso et
al.23 reported similar results in 28 patients with a FSH/LH ratio >3.
Shrim et al.24 chose the cut-off ratio as 3 and found lower
pregnancy rates in  41 patients with an elevated FSH/LH ratio. In
contrast to these previous studies our study included only 6 women
out of 199 with a FSH/LH ratio >3. The reason for the differences of
the outcomes between our study and previous studies is probably
that women with basal FSH values lower than 12 IU/dl were
included. This value has been set as our clinic’s upper FSH level for
expecting good  ovarian response to controlled ovarian stimulation.
Comparable pregnancy rates were found for all the groups with 0.5
ratio increments starting from 1.
Mukherjee et al.22 suggested that the poor response to ovarian
stimulation could be due to low day 3 LH concentrations since
there were no differences in day 3 FSH values between the two
groups. Nocci et al.25 and Mukherjee et al.26 argued that a
decreased day 3 LH concentration (which could be reflected as an
elevated FSH/LH ratio) is predictive of a reduced ovarian response.
They speculated that there might be reduced activity of one or
more of the known ovarian regulators when the early follicular LH
concentration was low, and that this could influence follicular
growth. Alternatively, a low LH concentration could simply be a
marker of impaired balance between the gonad and the pituitary
gland. Similarly,  the mean day 3 LH concentrations decreased in
our study as the FSH/LH ratio increased. The mean day 3 LH
concentration in the highest ratio group was significantly lower
than in the other groups. However,  the mean LH concentrations in
all of our groups were higher than 3 mIU/ml; thus our patients had
higher basal LH values in contrast to those reported by Mukherjee.
Our study group D had the lowest mean day 3 LH concentration
and the lowest number of total oocytes and metaphase II oocytes
were collected, which supports Noci’s speculation25 that there
could be reduced activity of one or more of the known ovarian
regulators when the early follicular LH concentration is  low. The
difference  in mean LH levels between our study groups did not
reflect on pregnancy rates between the groups.  In group D of our
study, 8 women out of 21 had LH concentration lower than 3
IU/ml, the percentage being higher than for the previous three
groups (2/65; 4/70 and 5/43 in groups A, B and C; respectively). 
Our study population had cycle day 3 serum FSH levels within
normal limits. The increase in FSH/LH ratio is the result of both the
decrease in LH and the elevated FSH values. Although lower LH
values had been previously23,24 reported as the cause of the high
FSH/LH ratio, no association between follicular phase serum LH levels
and IVF pregnancy outcomes were confirmed27,28. We could not
obtain the results suggested by Liu and Greenblatt29. Our group with
the lowest mean serum LH value had the least number of fertilized
oocytes. Since a comparable number of embryos were transferred,
similar pregnancy outcomes with the other groups with higher
serum LH levels but lower FSH/LH ratios could be achieved.
Table III . Multivariate analysis
Odds P 95% confidence
Ratio value interval 
Clinical pregnancy rate
Age 0.88 0.07 0.77-1.01
AFC 1.09 0.29 0.93-1.27
Duration of stimulation 1.30 0.19 0.88-1.95
Total dose of FSH used 0.99 0.58 0.99-1.00
Number of oocytes collected 0.93 0.48 0.76-1.14
Day 3 FSH 0.70 0.06 0.49-1.02
Day 3 LH 1.14 0.22 0.92-1.42
Day 3 FSH/ LH ratio 1.81 0.066 0.96-3.41
Odds P 95% confidence 
Ratio value interval 
Ongoing pregnancy rate
Age 0.97 0.68 0.86-1.11
AFC 1.08 0.34 0.92-1.27
Duration of stimulation 1.51 0.06 0.98-2.35
Total dose of FSH used 0.99 0.37 0.99-1.00
Number of oocytes collected 0.98 0.83 0.81-1.18
Day 3 FSH 0.81 0.23 0.57-1.14
Day 3 LH 1.08 0.44 0.88-1.32
Day 3 FSH/ LH ratio 0.93 0.84 0.44-1.94
Odds P 95% confidence 
Ratio value interval 
Cycle cancellation rate
Age 1.03 0.75 0.86-1.24
AFC 0.79 0.055 0.62-1.01
Duration of stimulation 1.17 0.74 0.45-3.03
Total dose of FSH used 1.00 0.71 0.99-1.00
Number of oocytes collected 1.45 0.27 0.76-2.76
Day 3 FSH/ LH ratio 0.75 0.59 0.27-2.11
AFC: antral follicule count
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Conclusion
Elevated FSH/LH ratio22,23 or low day 3 LH levels in the
presence of normal baseline FSH24-26 were associated with an
inferior IVF outcome. On the basis of our findings, it seems that the
FSH/LH ratio cannot be used to predict the ICSI success in women
with normal baseline FSH levels as long as a comparable number of
good quality embryos are transferred on day 3. 
Acknowledgement 
The authors declare that they have no conflict of interest.
References
1. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde
ER. Predictors of poor ovarian response in in vitro fertilization: a
prospective study comparing basal markers of ovarian reserve. Fertil Steril
2002;77:328-36. doi: 10.1016/S0015-0282(01)02983-1
2. Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ. Antral follicle
count in the prediction of poor ovarian response and pregnancy after in
vitro fertilization: a meta-analysis and comparison  with basal follicle-
stimulating hormone level. Fertil Steril 2005;83: 291-301. 
doi:10.1016/j.fertnstert.2004.10.011
3. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic
review of tests predicting ovarian reserve and IVF outcome. Hum Reprod
Update 2006;12:685-718. doi:10.1093/humupd/dml034
4. Mol BW, Verhagen TE, Hendriks DJ, et al. Value of ovarian reserve testing
before IVF: a clinical decision analysis. Hum Reprod 2006;21:1816-23.
5. Muasher SJ, Oehninger S, Simonetti S. The value of basal and/or
stimulated serum gonadotropin levels in prediction of stimulation
response and in vitro fertilization outcome. Fertil Steril  1998;50:298-307.
6. Tanbo  T, Dale  P O, Lunde O. Prediction of response to controlled ovarian
hyperstimulation: a comparison of basal and clomiphene citrate-
stimulated follicle-stimulating hormone levels. Fertil Steril 1992;57:819-24.
7. Winslow KL, Toner JP, Brzyski RG. The  gonadotrophin releasing hormone
agonist stimulation test - a sensitive predictor of performance in the flare-
up in vitro fertilization cycle. Fertil Steril 1991;56:711-17.
8. Franchin R, De Ziegler D, Olivennes F. Exogenous follicle stimulating
hormone ovarian reserve test (EFORT): a simple and reliable screening test
for detecting ‘poor responders’ in in vitro fertilization. Hum Reprod 1994;
9:1607-11.
9. Smotrich DB., Widra EA, Gindoff PR. Prognostic value of day 3 estradiol
on in vitro fertilization outcome. Fertil Steril 1995; 64: 1136-40. 
10. Van er Spuy ZM, Alberts PJ. Ovarian reserve. In: Healy DL, Kovacs GT,
McLachlan R, Rodriguez-Armas O, eds.  Reproductive Medicine in the
Twenty-First Century. London: Parthenon, 2002; 295-305.
11. Sharara FI, Scott RT Jr , Seifer DB. The detection of diminished ovarian
reserve in infertile women. Am J Obstet Gynecol 1998; 179: 804-12.
12. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations
as prognosticators of ovarian stimulation response and pregnancy
outcome in patients undergoing in vitro fertilization. Fertil Steril
1995;64:991-4. 
13. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low
ovarian response to stimulation for IVF: a systematic review. Hum Reprod
Update 2003;9:61-76.  doi: 10.1093/humupd/dmg007
14. Barnhart K, Osherhoff J. Follicule stimulating hormone as a predictor of
fertility. Curr Opin Obstet Gynecol 1998;10:227-32.
15. Fasouliotis SJ, Simon A, Laufer N. Evaluation and treatment of low
responders in assisted reproductive technology: a challenge to meet. J
Assist Reprod Genet 2000;17:357-73.  doi: 10.1023/A:1009465324197
16. Bukman A., Heineman MJ. Ovarian reserve testing and the use of
prognostic models in patients with subfertility Hum Reprod Update
2001;7:581-90. doi: 10.1093/humupd/7.6.581
17. Creus M, Peñarrubia J, Fábregues F, et al. Day 3 serum inhibin B and FSH
and age as predictors of assisted reproduction treatment outcome Hum
Reprod 2000;15:2341-6. doi: 10.1093/humrep/15.11.2341
18. Lass A, Gerrard A, Abusheikha N, Akagbosu F, Brinsden P. IVF performance
of women who have fluctuating early follicular FSH levels. J Assist Reprod
Genet 2000;17:566-73.
19. Peñarrubia J, Balasch J, Fábregues F,  et al. Day 5 inhibin B serum
concentrations as predictors of assisted reproductive technology outcome
in cycles stimulated with gonadotrophin-releasing hormone agonist-
gonadotrophin treatment. Hum Reprod  2000;15:1499-504. 
doi: 10.1093/humrep/15.7.1499
20. Scott RT Jr, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability
of day 3 follicle-stimulating hormone levels and its effect on stimulation
quality in in vitro fertilization. Fertil Steril  1990;54:297-302.
21. Martin JS, Nisker JA, Tummon IS, Daniel SA, Auckland JL, Feyles V. Future
in vitro fertilization pregnancy potential of women with variably elevated
day 3 follicle-stimulating hormone levels. Fertil Steril 1996;65:1238-40. 
22. Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld
L. An elevated day three follicle-stimulating hormone:luteinizing
hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts
a poor response to controlled ovarian hyperstimulation. Fertil Steril
1996;65:588-93.
23. Barroso G, Oehninger S, Monzo A, Kolm P, Gibbons WE, Muasher SJ. High
FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular
development and IVF outcome. J Assist Reprod Genet 2001;18:499-505.
doi: 10.1093/humrep/dep254
24. Shrim A, Elizur SE, Seidman DS, Rabinovici J,Wiser A, Dor J. Elevated day
3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian
response. Reprod Biomed Online 2006;12:418-22.
25. Noci I, Biagiotti R, Maggi M, Ricci F, Cinotti A, Scarselli G. Low day 3
luteinizing hormone values are predictive of reduced response to ovarian
stimulation. Hum Reprod 1998;13:531-4. 
doi: 10.1093/humrep/ 14.3.863
26. Mukherjee T, Copperman AB, Rosen T. Low day three LH in the presence
of a normal baseline FSH predicts a poor response to controlled ovarian
hyperstimulation. Abstracts, 51st Annual Meeting of the American Society
for Reproductive Medicine, October 7-12, 1995, Seattle, Washington,
USA, abstract 0-020:511.
27. Bosch E, Escudero E, Crespo J, Simon C, Remohi J, Pellicer A. Serum
luteinizing hormone in patients undergoing ovarian stimulation with
gonadotropin-releasing hormone antagonists and recombinant follicle-
stimulating hormone and its relationship with cycle outcome. Fertil Steril
2005;84:1529-32. doi:10.1016/j.fertnstert.2005.05.040
28. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E, Devroey P. Are
endogenous LH levels during ovarian stimulation for IVF using GnRH
analogues associated with the probability of ongoing pregnancy? A
systematic review. Hum Reprod Update 2006;12:3-12. 
doi: 10.1093/humupd/dmi030
29. Liu KE, Greenblatt EM. Elevated day 3 follicle-stimulating hormone/
luteinizing hormone ratio ≥ 2 is associated with higher rates of
cancellation in in vitro fertilization-embryo transfer cycles. Fertil Steril
2008;90:297-301. 
Marmara Medical Journal 2012;25:69-73
Yoldemir et al.
The Predictivity of FSH/LH Ratio on ICSI Success 73
